Mindfulness-Based fMRI Neurofeedback for Depression
mbNF
Targeting Adolescent Depression Symptoms Using Network-based Real-time fMRI Neurofeedback and Mindfulness Meditation (NIMH); Mindfulness-Based Real-Time fMRI Neurofeedback for Depression (IRB)
2 other identifiers
interventional
90
1 country
2
Brief Summary
In the United States, adolescents experience alarmingly high rates of major depression, and gold-standard treatments are only effective for approximately half of patients. Rumination may be a promising treatment target, as it is well-characterized at the neural level and contributes to depression onset, maintenance, and recurrence as well as predicts treatment non-response. Accordingly, the proposed research will investigate whether an innovative mindfulness-based real-time functional magnetic resonance imaging (fMRI) neurofeedback intervention successfully elicits change in the brain circuit underlying rumination to improve clinical outcomes among depressed adolescents.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2024
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 1, 2022
CompletedFirst Posted
Study publicly available on registry
November 15, 2022
CompletedStudy Start
First participant enrolled
April 10, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 30, 2027
April 29, 2026
April 1, 2026
2.8 years
November 1, 2022
April 24, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Within-person Default Mode Network (DMN) Connectivity
DMN change will be assessed via fMRI from before mbNF.
Pre-mbNF procedure
Within-person Default Mode Network (DMN) Connectivity
DMN connectivity will be assessed via fMRI from post mbNF. Changes in DMN connectivity following mbNF are anticipated.
Post-mbNF procedure
Secondary Outcomes (8)
Self-Report Depression Symptoms
Pre-mbNF procedure
Self-Report Depression Symptoms
Immediately Post-mbNF procedure
Self-Report Depression Symptoms
1-month
Interviewer-Assessed Depression Symptoms
Baseline
Interviewer-Assessed Depression Symptoms
1-month
- +3 more secondary outcomes
Other Outcomes (7)
Ecological Momentary Assessment of Depression Symptoms
Immediately Post-mbNF procedure
Ecological Momentary Assessment of Depression Symptoms
1-month
Ecological Momentary Assessment of Rumination
Immediately Post-mbNF procedure
- +4 more other outcomes
Study Arms (2)
15-Minute mbNF
ACTIVE COMPARATORParticipants receiving mindfulness training and 15-minute session of mbNF
30-Minute mbNF
ACTIVE COMPARATORParticipants receiving mindfulness training and 30-minute session of mbNF
Interventions
Prior to neurofeedback, participants will receive 45 minutes of mindfulness training. Participants will then receive mindfulness-based fMRI neurofeedback targeting the default mode network and frontoparietal control network.
Eligibility Criteria
You may qualify if:
- Ages 13-18 years-old
- Written informed assent/consent and parental/guardian permission for 13-17 year-olds or informed consent for 18 year-olds
- Tanner puberty stage ≥3
- Meets current diagnostic criteria for MDD
- English fluency
You may not qualify if:
- Lifetime history of primary psychotic disorders, bipolar disorder, oppositional defiant disorder, conduct disorder, developmental disorder (e.g., autism), post-traumatic stress disorder, or eating disorders
- Substance use disorder, moderate or severe in past 6 months
- Active suicidal ideation with a specific plan
- History of seizure disorder
- Medical or neurological illness (e.g., severe head injury)
- MRI contraindications
- Current psychotropic medication use other than antidepressant medication
- Intelligence quotient (IQ) \<80.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Columbia Universitylead
- National Institute of Mental Health (NIMH)collaborator
Study Sites (2)
Northeastern University
Boston, Massachusetts, 02115, United States
Columbia University Irving Medical Center
New York, New York, 10032, United States
Related Publications (1)
Bloom PA, Pagliaccio D, Zhang J, Bauer CCC, Kyler M, Greene KD, Treves I, Morfini F, Durham K, Cherner R, Bajwa Z, Wool E, Olafsson V, Lee RF, Bidmead F, Cardona J, Kirshenbaum JS, Ghosh S, Hinds O, Wighton P, Galfalvy H, Simpson HB, Whitfield-Gabrieli S, Auerbach RP. Mindfulness-based real-time fMRI neurofeedback: a randomized controlled trial to optimize dosing for depressed adolescents. BMC Psychiatry. 2023 Oct 17;23(1):757. doi: 10.1186/s12888-023-05223-8.
PMID: 37848857DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
November 1, 2022
First Posted
November 15, 2022
Study Start
April 10, 2024
Primary Completion (Estimated)
January 31, 2027
Study Completion (Estimated)
June 30, 2027
Last Updated
April 29, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share
De-identified data will be uploaded to the NIMH NDA.